Daniel F. B. Wright

1.5k total citations
73 papers, 1.0k citations indexed

About

Daniel F. B. Wright is a scholar working on Nephrology, Pharmacology and Statistics and Probability. According to data from OpenAlex, Daniel F. B. Wright has authored 73 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Nephrology, 18 papers in Pharmacology and 14 papers in Statistics and Probability. Recurrent topics in Daniel F. B. Wright's work include Gout, Hyperuricemia, Uric Acid (20 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Statistical Methods in Clinical Trials (14 papers). Daniel F. B. Wright is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (20 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Statistical Methods in Clinical Trials (14 papers). Daniel F. B. Wright collaborates with scholars based in New Zealand, Australia and United States. Daniel F. B. Wright's co-authors include Stephen B. Duffull, Helen Winter, Murray L. Barclay, Lisa K. Stamp, Megan Anakin, Tony R. Merriman, H. M. Perry, Nicola Dalbeth, Evan J. Begg and Robert Walker and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Daniel F. B. Wright

66 papers receiving 1.0k citations

Peers

Countries citing papers authored by Daniel F. B. Wright

Since Specialization

Citations

This map shows the geographic impact of Daniel F. B. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel F. B. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel F. B. Wright more than expected).

Fields of papers citing papers by Daniel F. B. Wright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel F. B. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel F. B. Wright. The network helps show where Daniel F. B. Wright may publish in the future.

Co-authorship network of co-authors of Daniel F. B. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel F. B. Wright. A scholar is included among the top collaborators of Daniel F. B. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel F. B. Wright. Daniel F. B. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk of bias tools for medication adherence research: RoBIAS and RoBOAS 2025 ·British Journal of Clinical Pharmacology ·(unknown), Dyfrig Hughes, Sophie L. Stocker, Daniel F. B. Wright, (unknown)	0
2	Dosing practices, pharmacokinetics, and effectiveness of allopurinol in gout patients receiving dialysis: a scoping review 2025 ·Journal of Nephrology ·(unknown), M. Stokes, Daniel F. B. Wright, Kamal Sud, (unknown), Ronald L. Castelino, Sophie L. Stocker	0
3	A Pharmacometric Workflow for Resolving Model Instability in Model Use‐Reuse Settings 2025 ·CPT Pharmacometrics & Systems Pharmacology ·Stephen B. Duffull, Daniel F. B. Wright, Xiao Zhu, Xin Liu, (unknown), (unknown)	2
4	The Influence of Patient Factors on the Population Pharmacokinetics of Colchicine: Implications for Safe and Effective Dosing 2025 ·Clinical Pharmacokinetics ·Daniel F. B. Wright, (unknown), Nicola Dalbeth, Anne Horne, Jill Drake, (unknown), Lisa K. Stamp	0
5	The development and evaluation of dose‐prediction tools for allopurinol therapy (Easy‐Allo tools) 2024 ·British Journal of Clinical Pharmacology ·Daniel F. B. Wright, (unknown), Sophie L. Stocker, Nicola Dalbeth, Anne Horne, Jill Drake, (unknown), Amanda Phipps‐Green, Tony R. Merriman, Lisa K. Stamp	6
6	The experiences and perspectives of people with gout on urate self‐monitoring 2024 ·Health Expectations ·(unknown), (unknown), (unknown), Daniel F. B. Wright, (unknown), Dyfrig Hughes, Richard O. Day, Parisa Aslani, Sophie L. Stocker	1
7	Patient‐Led Urate Self‐Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility Study 2024 ·ACR Open Rheumatology ·(unknown), Daniel F. B. Wright, (unknown), (unknown), Parisa Aslani, Dyfrig Hughes, Richard O. Day, Sophie L. Stocker	3
8	The impact of peritoneal dialysis on oxypurinol and urate elimination in people with gout 2024 ·Nephrology ·Luke C. Wilson, (unknown), Daniel F. B. Wright, (unknown), Sophie L. Stocker, (unknown), John Schollum, Robert Walker	1
9	The influence of flip‐flop in population pharmacokinetic analyses 2023 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), Daniel F. B. Wright, Stephen B. Duffull	5
10	A framework for understanding sources of bias in medication adherence research 2023 ·British Journal of Clinical Pharmacology ·(unknown), Dyfrig Hughes, Sophie L. Stocker, Bernard Vrijens, Jeffrey K Aronson, Daniel F. B. Wright	4
11	An allopurinol adherence tool using plasma oxypurinol concentrations 2022 ·British Journal of Clinical Pharmacology ·(unknown), Sophie L. Stocker, Lisa K. Stamp, Nicola Dalbeth, Amanda Phipps‐Green, Tony R. Merriman, Daniel F. B. Wright	2
12	Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy 2020 ·The Annual Review of Pharmacology and Toxicology ·Adam S. Darwich, Thomas M. Polasek, Jeffrey K Aronson, Kayode Ogungbenro, Daniel F. B. Wright, Brahim Achour, Jean‐Luc Reny, Youssef Daali, Birgit Eiermann, Jack Cook, Lawrence J. Lesko, Andrew J. McLachlan, Amin Rostami‐Hodjegan	109
13	The propagation of between‐subject variability from dose to response 2020 ·British Journal of Clinical Pharmacology ·Hesham Al‐Sallami, Daniel F. B. Wright, Stephen B. Duffull	0
14	Evaluation of Assumptions Underpinning Pharmacometric Models 2019 ·The AAPS Journal ·(unknown), Daniel F. B. Wright, Geoffrey K. Isbister, Stephen B. Duffull	3
15	A philosophical framework for pharmacy in the 21st century guided by ethical principles 2017 ·Research in Social and Administrative Pharmacy ·Stephen B. Duffull, Daniel F. B. Wright, Carlo A. Marra, Megan Anakin	25
16	Dabigatran in patients with mechanical heart valves. 2014 ·New England Journal of Medicine ·Paul K. L. Chin, Daniel F. B. Wright, Evan J. Begg	0
17	Methods for Predicting Warfarin Dose Requirements 2014 ·Therapeutic Drug Monitoring ·Shamin Mohd Saffian, Daniel F. B. Wright, Rebecca L. Roberts, Stephen B. Duffull	15
18	Development of a Bayesian Forecasting Method for Warfarin Dose Individualisation 2011 ·Pharmaceutical Research ·Daniel F. B. Wright, Stephen B. Duffull	24
19	Interpreting population pharmacokinetic‐pharmacodynamic analyses – a clinical viewpoint 2010 ·British Journal of Clinical Pharmacology ·Stephen B. Duffull, Daniel F. B. Wright, Helen Winter	100
20	Trace element deficiencies-a new approach to diagnosis 1984 ·Proceedings of the New Zealand Society of Animal Production ·Daniel F. B. Wright, R.G. Clark, (unknown), James Rowland	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact